Current Studies

A phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK’s meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults

Find out more about this study

Please fill out the form below and we will be in touch shortly.

Participants needed: 16-17

Purpose
Meningococcal disease is caused by the bacteria Neisseria meningitidis and can result in very severe disease such as sepsis (blood infection) and meningitis. There are currently vaccines that protect against 4 different types (A, C, W, Y) being used across Canada and doctors want to protect against type B too

Eligibility
Healthy 16- 17 year olds who are have not received a Men ACWY Vaccination in the last 4 years.

What is involved
Participants will receive a MenACWY + B vaccine. There will be 6 visits to the study clinic and 7 phone calls over the course of 12 months. These visits will include a physical exam, vaccinations, blood tests, and questions about your health. . You will receive: Eligible participants will be reimbursed for travel/parking & receive a gift card at each visit.

Before any study activities are performed, you and your parent/guardian will be asked to review and sign the consent form .

Find out more about this study

Please fill out the form below and we will be in touch shortly.